Objectives: Endovascular aneurysm repair for ruptured abdominal aortic aneurysms (r-EVAR) has increased over the years. Ruptured abdominal aortic aneurysms (rAAA) usually present with more hostile anatomy, and planning is performed under time pressure. Consequently, more complications during follow-up may arise. Additionally, it is unknown whether the same sac dynamics can be expected after repair between elective (el-EVAR) and r-EVAR. This study evaluated differences in outcomes and sac dynamics between r-EVAR and el-EVAR.
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Methods:
The Global Registry for Endovascular Aortic Treatment (GREAT) is an industry-sponsored prospective, multicenter, cohort registry that enrolled >5000 consecutive patients to report real-world data for the Gore abdominal and thoracic aortic endografts. Patients who underwent EVAR for infrarenal abdominal aortic aneurysm from August 2010 to November 2016 were identified from the registry. The incidence and outcome of patients with lower extremity ischemia and endograft limb occlusion were analyzed. Statistical analysis was performed to identify factors associated with lower extremity ischemia.
Results: Among the 3649 patients who were treated with the Excluder and C3 Excluder devices in the registry, 44 patients (1.2%) developed lower extremity ischemia, 16 patients (36%) developed endograft limb occlusion, and 25 patients had common femoral, femoral popliteal, or distal thrombosis. The incidence of endograft-related limb ischemia was 0.4%. All patients required additional procedures for revascularization, and none require major extremity amputation. Patients who developed extremity ischemia were significantly younger, more likely to be female, had history of peripheral vascular disease (PVD), and had smaller distal limb diameter (Table) . In multivariable analysis, female gender (odds ratio [OR], 2.90; 95% confidence interval [CI], 1.52-5.52; P ¼ .001), younger age (OR, 0.96; 95% CI, 0.93-0.99; P ¼ .018), and history of PVD (OR, 5.96; 95% CI, 3.24-10.99; P < .001) were associated with lower extremity ischemia.
Conclusions: The incidences of lower extremity ischemia and endograft limb occlusion in real-world practice are uncommon with the Excluder endograft. Female gender, younger age, and history of PVD were factors associated with lower extremity ischemia after EVAR. 
